2025 third_quarter Filing
Q3Income
$60K
Filed
October 20, 2025
Lobbying Activities (4)
Copyright/Patent/Trademark
View allMonitored issues related to intellectual property.
HOUSE OF REPRESENTATIVESSENATE
Taxation/Internal Revenue Code
View allH.R. 1 (P.L. 119-21), One Big Beautiful Bill Act, as it relates to corporate taxes.
HOUSE OF REPRESENTATIVESSENATE
Medicare/Medicaid
View allMonitored implementation of P.L. 117-169, the Inflation Reduction Act as it relates to drug pricing. Issues related to biosimilars. Monitored issues related to cardiovascular health. Issues related to pharmacy benefit management. Monitored issues related to dialysis services.
H.R. 1 (P.L. 119-21), One Big Beautiful Bill Act, as it relates to pharmacy benefit management and drug pricing policies.
H.R. 946 / S. 1862, ORPHAN Cures Act. Issues related to the Most Favored Nation drug pricing.
SENATECenters For Medicare and Medicaid Services (CMS)Executive Office of the President (EOP)Health & Human Services, Dept of (HHS)HOUSE OF REPRESENTATIVESOffice of Management & Budget (OMB)
Health Issues
View allIssues related to pharmacy benefit management. Issues related to cardiovascular care. Issues related to drug pricing.
Centers For Medicare and Medicaid Services (CMS)Executive Office of the President (EOP)Health & Human Services, Dept of (HHS)HOUSE OF REPRESENTATIVESSENATE
Lobbyists (5)
MARY BETH SAVARY TAYLOR
GREG D'ANGELO
BRETT BAKER
JEFF CHOUDHRY